An ETF to Capture Biotech’s Breakthrough of the Century

This article was originally published on

Health care investors should look to biotechnology sector-related ETFs that tap into some exciting new technologies that could translate into growth potential, such as CRISPR, biotech’s breakthrough of the century. On the recent webcast (available On Demand for CE Credit), The Power of Genome Editing: What Investors Should Know, Manisha Samy, Analyst Genomic Revolution at [...]

Read more at >